AbbVie Inc.ABBVNYSE
Loading
EBITDA Over TimeExpanding
Percentile Rank100
3Y CAGR+5.4%
5Y CAGR+18.1%
Year-over-Year Change
Earnings before interest, taxes, depreciation, and amortization
3Y CAGR
+5.4%/yr
vs +30.6%/yr prior
5Y CAGR
+18.1%/yr
Recent deceleration
Acceleration
-25.2pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.3x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $28.29B | +89.8% |
| 2024 | $14.91B | -13.2% |
| 2023 | $17.17B | -29.0% |
| 2022 | $24.17B | +1.0% |
| 2021 | $23.93B | +94.2% |
| 2020 | $12.32B | +0.8% |
| 2019 | $12.23B | +47.1% |
| 2018 | $8.31B | -19.9% |
| 2017 | $10.38B | +2.5% |
| 2016 | $10.12B | - |